Dova Pharmaceuticals Inc. 4 SEC Filings

Filed On	Filing
15 Nov 2019	Form 4: Perceptive Advisors Llc, 10% owner and 2 others Disposed of 3,125,851 shares (Other Transaction)
12 Nov 2019	Form 4: Zaccardelli David, Director Returned 76,647 shares to the issuer · Disposed of 1,000,000 Employee Stock Option (Right to Buy) (Disposition to Issuer)
12 Nov 2019	Form 4: Wysenski Nancy, Director Returned 6,274 shares to the issuer · Disposed of 10,000 Stock Option (Right to Buy) (Disposition to Issuer)
12 Nov 2019	Form 4: Stalfort Sean, Director Disposed of 635,665 shares (Tender Offer) ($17.5M)
12 Nov 2019	Form 4: Novak Alfred J, Director Returned 6,901 shares to the issuer · Disposed of 43,000 Stock Option (Right to Buy) (Disposition to Issuer)
12 Nov 2019	Form 4: Manning Paul B, Director Disposed of 14,762,242 shares (Tender Offer) ($406M)
12 Nov 2019	Form 4: Laliberte Kevin, Sr. VP, Product Development Returned 4,761 shares to the issuer · Disposed of 200,250 Employee Stock Option (Right to Buy) (Disposition to Issuer)
12 Nov 2019	Form 4: Jeffs Roger, Director Returned 66,993 shares to the issuer · Disposed of 43,000 Stock Option (Right to Buy) (Disposition to Issuer)
12 Nov 2019	Form 4: Hoitt Jason, Chief Commercial Officer Returned 9,970 shares to the issuer · Disposed of 250,000 Employee Stock Option (Right to Buy) (Disposition to Issuer)
12 Nov 2019	Form 4: Hahn Mark W, Chief Financial Officer Returned 9,024 shares to the issuer · Disposed of 300,000 Employee Stock Option (Right to Buy) (Disposition to Issuer)
12 Nov 2019	Form 4: Goldman Steven M., Director Returned 149,280 shares to the issuer · Disposed of 18,416 Stock Option (Right to Buy) (Disposition to Issuer)
12 Nov 2019	Form 4: Allen Lee F Md PhD, Chief Medical Officer Returned 9,635 shares to the issuer · Disposed of 261,466 Employee Stock Option (Right to Buy) (Disposition to Issuer)
02 Oct 2019	Form 4: Zaccardelli David, Director Sold 5,275 shares ($147K)
02 Oct 2019	Form 4: Allen Lee F Md PhD, Chief Medical Officer Sold 978 shares ($27.4K)
02 Oct 2019	Form 4: Hahn Mark W, Chief Financial Officer Sold 775 shares ($21.7K)
02 Oct 2019	Form 4: Hoitt Jason, Chief Commercial Officer Sold 2,387 shares ($66.8K)
02 Oct 2019	Form 4: Laliberte Kevin, Sr. VP, Product Development Sold 3,696 shares ($103K)
27 Sep 2019	Form 4: Laliberte Kevin, Sr. VP, Product Development Sold 3,100 shares ($62K)
12 Aug 2019	Form 4: Manning Paul B, Director Bought 28,062 shares ($445K)
01 Aug 2019	Form 4: Laliberte Kevin, Sr. VP, Product Development Granted 10,000 Employee Stock Option (right to buy) · Sold 1,389 shares ($22.2K)

Comments